Sagimet Biosciences SGMT
NASDAQ SGMT
$9.33 -0.61 (-6.14%)
At close: Sep 29, 2026 · 4:00 PM EDT

Sagimet Biosciences (SGMT) Share-based Compensation (2022 - 2026)

Updated

Sagimet Biosciences' Share-based Compensation came in at $3.69 million for Q2 2026, up 131.0% from $1.6 million a year earlier and up 100.7% from the prior quarter.

Analysis

Sagimet Biosciences (SGMT) Share-based Compensation (2022 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Sagimet Biosciences reported Share-based Compensation of $8.91 million, up 44.9% year-over-year; for FY2025, it was $6.45 million, up 22.0% from FY2024.

  • Share-based Compensation has increased in each of the last three years, with a three-year compound annual growth rate of 50.8% (FY2022 to FY2025).
  • Going back by year, Share-based Compensation was $5.29 million in FY2024 (+6.0%), $4.99 million in FY2023 (+165.4%) and $1.88 million in FY2022.
  • The Q2 2026 figure represents the highest quarterly Share-based Compensation in data going back to Q3 2022.
  • Year-over-year, Share-based Compensation has increased for seven consecutive quarters, with growth averaging 35.0% over the last eight quarters.
  • The fastest year-over-year change in Share-based Compensation over five years came in Q3 2023 (growth of 376.9%), and the weakest in Q3 2024 (a decline of 16.7%).
  • Business Quant data shows SGMT's Share-based Compensation at $1.84 million (Q1 2026), $1.69 million (Q4 2025) and $1.69 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Sagimet Biosciences 527.96 Mn 527.96 Mn - 3.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.69 Mn
Mar 31, 2026 1.84 Mn
Dec 31, 2025 1.69 Mn
Sep 30, 2025 1.69 Mn
Jun 30, 2025 1.60 Mn
Mar 31, 2025 1.47 Mn
Dec 31, 2024 1.53 Mn
Sep 30, 2024 1.55 Mn
Jun 30, 2024 1.45 Mn
Mar 31, 2024 759,000.00
Dec 31, 2023 1.31 Mn
Sep 30, 2023 1.86 Mn
Jun 30, 2023 1.06 Mn
Mar 31, 2023 767,000.00
Dec 31, 2022 721,000.00
Sep 30, 2022 389,000.00
API Access

Sagimet Biosciences Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=SGMT&period=max&api_key=YOUR_API_KEY